Literature DB >> 29043554

Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance.

Alessia Gimelli1, Riccardo Liga2, Serena Magro1,3, Salvatore Novo3, Roberto Pedrinelli4, Anna Sonia Petronio4, Paolo Marzullo1,5, Alessia Pepe1.   

Abstract

BACKGROUND: Single-photon emission computed tomography has shown relevant limitations in the quantification of left ventricular (LV) mass. We sought to compare the estimates of LV mass on Cadmium-Zinc-Telluride (CZT) myocardial perfusion imaging (MPI) as compared to cardiac magnetic resonance (CMR). METHODS AND
RESULTS: Twenty-five patients underwent MPI on a CZT camera and CMR on a 1.5 T scanner within 12 ± 3 weeks. LV mass was quantified on CZT images using two softwares: 4D-MSPECT (4DM) and Emory Cardiac Toolbox (ECTb). LV mass by CMR was quantified using MASS software (Medis, Leiden, The Netherlands). LV mass values obtained with 4DM and ECTb were highly reproducible [intraclass correlation coefficients .98 (95% CI .97-.99), and .98 (95% CI 0.97-.99), respectively]. The mean LVM mass values were 151 ± 44 g on CMR, 151 ± 43 g with 4DM (P = NS vs CMR), and 157 ± 42 g with ECTb (P < .001 vs CMR; P = .007 vs 4DM) CZT images. There was an excellent correlation between LV mass values between CMR and both 4DM (R2 = .95; P < .001) and ECTb (R2 = .98; P < .001) with narrow limits of agreement (- 13.6% to + 13.4% for 4DM, and - 5.6% to + 14.1% for ECTb).
CONCLUSIONS: The evaluation of LV mass is feasible on CZT images, showing excellent agreement with CMR.

Entities:  

Keywords:  Cadmium-Zinc-Telluride; SPECT; cardiac magnetic resonance; left ventricular mass

Year:  2017        PMID: 29043554     DOI: 10.1007/s12350-017-1086-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

Review 1.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

Authors:  B H Lorell; B A Carabello
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

2.  Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance.

Authors:  A M Maceira; S K Prasad; M Khan; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

3.  Corridor4DM: the Michigan method for quantitative nuclear cardiology.

Authors:  Edward P Ficaro; Benjamin C Lee; James N Kritzman; James R Corbett
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

4.  Left ventricular mass from gated SPECT myocardial perfusion imaging: comparison with cardiac computed tomography.

Authors:  Tochi M Okwuosa; Chetan V Hampole; Javid Ali; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2009-08-01       Impact factor: 5.952

5.  Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function.

Authors:  Michael L Chuang; Philimon Gona; Gilion L T F Hautvast; Carol J Salton; Susan J Blease; Susan B Yeon; Marcel Breeuwer; Christopher J O'Donnell; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

6.  Prognostic implications of left ventricular hypertrophy.

Authors:  B A Vakili; P M Okin; R B Devereux
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

7.  Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor study.

Authors:  Giovanni Donato Aquaro; Giovanni Camastra; Lorenzo Monti; Massimo Lombardi; Alessia Pepe; Silvia Castelletti; Viviana Maestrini; Giancarlo Todiere; Piergiorgio Masci; Gabriella di Giovine; Andrea Barison; Santo Dellegrottaglie; Martina Perazzolo Marra; Gianluca Pontone; Gianluca Di Bella
Journal:  J Magn Reson Imaging       Date:  2016-08-29       Impact factor: 4.813

8.  Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.

Authors:  Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Massimo Midiri; Massimiliano Missere; Gianluca Valeri; Francesco Sorrentino; Domenico Giuseppe D'Ascola; Anna Spasiano; Aldo Filosa; Liana Cuccia; Nicola Dello Iacono; Gianluca Forni; Vincenzo Caruso; Aurelio Maggio; Lorella Pitrolo; Angelo Peluso; Daniele De Marchi; Vincenzo Positano; John C Wood
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-03-01       Impact factor: 6.875

9.  Diagnostic evaluation of three cardiac software packages using a consecutive group of patients.

Authors:  Lena Johansson; Milan Lomsky; Jens Marving; Mattias Ohlsson; Sven-Eric Svensson; Lars Edenbrandt
Journal:  EJNMMI Res       Date:  2011-09-30       Impact factor: 3.138

10.  Assessment of left ventricular mass and volumes by three-dimensional echocardiography in patients with or without wall motion abnormalities: comparison against cine magnetic resonance imaging.

Authors:  A-C Pouleur; J-B le Polain de Waroux; A Pasquet; B L Gerber; O Gérard; P Allain; J-L J Vanoverschelde
Journal:  Heart       Date:  2007-11-01       Impact factor: 5.994

View more
  4 in total

Review 1.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Med       Date:  2019-11       Impact factor: 10.057

2.  Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database.

Authors:  Shinro Matsuo; Kenichi Nakajima; Yasuchika Takeishi; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

3.  Assessment of left ventricular mass by SPECT MPI.

Authors:  René R Sevag Packard; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2017-12-14       Impact factor: 5.952

Review 4.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-10-25       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.